overal result line ahead expect importantli underli growth
momentum across key busi intact though time unfavor impact result
degre guidanc impli growth year previous
expect manag confid phase outlook note
execut solid guidanc reiter
overal revenu report compar fxn
ahead consensu expect forecast line
mid-januari pre-announc note reduc revenu forecast
subsequ decemb meet manag link better account
fx pace time order sub-seg compar fxn revenu
growth bd medic bd life scienc exceed forecast bd intervent
compar revenu growth bit forecast appear
function time growth profil importantli growth least
line manag expect page addit revenu detail
gross margin y/i oper margin y/i
consensu estim respect ep y/i
ahead consensu estim forecast consist
pre-announc ep benefit lower expect tax rate though
non-oper item unfavor recal manag guid ep
exclud favor tax rate unfavor non-oper item ep
would approxim still solid posit bd least hit full year
compar fxn revenu growth guid
full year guidanc rang low end manag note revenu growth
expect unfavor impact difficult flu comparison repres
growth headwind time order primarili relat
repres growth headwind fx also expect pronounc
impact result combin full year averag revenu growth rate
possibl full year averag tax rate lead ep guidanc
well street expect head print note
manag explan reason aspect guidanc includ compar
fxn revenu growth oper margin ep
reiter
revenu ep growth typic appear manag
good visibl time new product launch order addit execut
solid appear underli demand deterior share
trade discount peer price-to-earnings basi
premium basi respect think risk/reward remain
pleas see page report import disclosur
appear well posit gener sustain msd top line ep growth
upsid oper target via on-going stand-alone improv carefus
upsid rel formal accretion/
price pressur like continu
volum pressur like intensifi
solid execut rel expect
carefusion/bard synergi accret
target conserv
strong growth emerg market
bd guidanc prove high
bard miss accret synergi
concern strategi
becton dickinson compani bd global medic technolog compani engag
develop manufactur sale medic devic instrument system
reagent use healthcar institut life scienc research clinic laboratori
pharmaceut industri gener public
compani report thomson eikon cowen compani
cowen vs consensu mm except report growth compar fxn growthgross fxn report hsd bard accretioncowen vs consensu mm except organ intervent neutral life growth vs consensu mm except forma compar fxn per count expens forecast oper margin y/i consensu expect ep y/i ahead consensu estim forecast consist pre-announc ep benefit lower expect tax rate though non-oper item unfavor recal manag guid ep exclud favor tax rate unfavor non-oper item ep would approxim still solid posit bd least hit full year guidanc bd life scienc revenu compar fxn deliv solid around quarter sub-seg come forecast overal revenu report compar fxn ahead consensu expect forecast line mid-januari pre-announc note reduc revenu forecast subsequ decemb meet manag link better account fx pace time order sub-seg compar fxn revenu growth bd medic bd life scienc exceed forecast bd intervent compar revenu growth bit forecast appear function time growth profil importantli growth least line manag expect gross margin y/i exceed consensu expect expens forecast bd medic revenu compar fxn beat forecast howev sub-seg perform bit mix medic deliveri solut md revenu forecast compar fxn growth note md benefit revenu synergi segment harbor cathet includ picc better expect medic manag solut growth off-set md weak bd intervent consist mostli legaci bard revenu compar fxn beat report forecast light compar fxn forecast fx less headwind expect said result line manag cowen
compani report cowen compani
fy end septemb end septemb end septemb year mm except report growth compar fxn growth reiter report growth expect back end load growth like neutral growth expect like ratabl despit compcomparable/underli fx headwind reiter acut impact neutral forma compar intervent reiter expect higher end rangefx neutral fxn reiter forma compar life neutral organ fxn reiter cowen
compani report thomson eikon cowen compani
mm except per share report growth compar fxn growth growth expect back end load growth like fx headwind reiter acut impact organ gross margin ramp consider sale gener sale oper fxn non-oper interest interest/oth reiter cowen note estim gore headwind full year rangepref convert share may earn per fxn report hsd bard accret reiter share ep share except per share gross op cowen
price target base sever methodolog may includ analysi market risk
group ev/ebitda premium discount averag group price-to-earnings sum part net asset
valu dividend return return equiti roe next month
risk medic life scienc tool sector may includ reduct delay research
develop budget govern fund reduc delay purchas
health care hospit custom increas extend regulatori hurdl process
regul product increas depend volatil emerg market revenu
profit gener macroeconom challeng
make invest recommend earli stage pre-commerci ls dt
compani base upon assess technolog probabl market success
competit regulatori reimburs etc potenti market opportun
event success howev compani lack tradit and/or matur
financi metric believ good methodolog assign specif
target price stock
downsid risk includ limit inabl execut integr
approv reduc reimburs patent infring product liabil lawsuit
macroeconom deterior current level eros market share price due
competit inabl deliv incremental/decrement margin target value-
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock secur
cowen compani llc manag co-manag public offer past month
cowen compani llc receiv compens invest bank servic past month
past month client cowen compani llc cowen compani llc provid provid invest bank servic
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
avenu floor new york ny addit import disclosur except valuat method risk avail firm disclosur
websit http //cowen bluematrix com/sellside/disclosur action
equiti research price target cowen compani llc assign price target compani cover equiti research unless note otherwis equiti research price target
issuer stock repres valu analyst reason expect stock reach perform period twelv month price target equiti secur
report consid context prior publish cowen compani llc equiti research report includ disclosur equiti report
firm disclosur websit may may includ equiti research price target well develop relat issuer industri financi market
equiti research price target valuat methodolog risk associ achiev given equiti research price target pleas see analyst equiti research report
publish target
cowen cross-asset research due natur fix incom market issuer debt secur issuer discuss cowen cross-asset research report
assign rate price target may continu follow accordingli investor must regard brand report provid stand-alon analysi reflect
analyst opinion date report expect continu analysi addit report relat issuer debt secur issuer
time time cowen cross-asset research analyst provid invest recommend secur subject report recommend intend
time date public within paramet specifi individu report cowen cross-asset research invest recommend made
strictli case-by-cas basi recommend provid part overarch rate system set consist appli benchmark view express
cross-asset research report may differ view offer firm equiti research report prepar client
notic uk investor public produc cowen compani llc regul unit state finra commun person kind
describ articl servic market act promot order must transmit person without
notic european union investor individu produc recommend requir obtain certain licens financi regulatori author finra review
author current licens statu histori employ histori report regulatori custom disput crimin matter via brokercheck finra http //
brokercheck finra org/ individu licens statu finra constru endors finra gener biograph inform also avail
research analyst www cowen com
addit complet preced recommend histori relat recommend research report avail http //cowen bluematrix com/sellside/
recommend contain report produc februari et dissemin februari et
copyright user agreement gener inform relat report
cowen compani llc right reserv member nyse finra sipc research report prepar exclus use cowen client may
reproduc display modifi distribut transmit disclos whole part form manner other outsid organ without express prior
written consent cowen cowen research report distribut simultan client elig receiv research report unauthor use disclosur
